<DOC>
	<DOCNO>NCT02084381</DOCNO>
	<brief_summary>The medium cut-off dialysis membrane develop provide significantly extend molecular cut-off compare conventional high-flux membrane . The medium cut-off membrane allow high permeability molecule molecular weight 45 kDa still limited permeability albumin ( 68 kDa ) . The main goal project evaluation new , highly porous selective dialysis membrane ( MCO-Ci 400 ) treatment patient end-stage renal disease hemodialysis mode study potential improve chronic inflammation .</brief_summary>
	<brief_title>PERCI- Medium Cut Off ( MCO )</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>CKD5 ( GFR &lt; 15ml/min/ 1.73m2 ) Dialysis treatment â‰¥ 3 month Dialysis 3x weekly Vascular access fistula CVC Age &gt; 18 &lt; 99 Years Ability give write informed consent Missing informed consent form current clinically manifested infection within last two week current CRPvalue &gt; 50mg/L within last two week Intake medication apply immunosuppressive purpose Pregnancy lactation Participation different interventional study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>CKD5 , dialysis , high porous membrane</keyword>
</DOC>